These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6274534

  • 21. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
    Hallahan DE, Vokes EE, Rubin SJ, O'Brien S, Samuels B, Vijaykumar S, Kufe DW, Phillips R, Weichselbaum RR.
    Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
    [Abstract] [Full Text] [Related]

  • 22. [A phase I study of TS-1 and weekly cisplatin in patients with advanced gastric cancer].
    Kondo K, Kinoshita M, Kataoka M, Shimoyama S, Yamamura K, Ohshima Y, Furuta K, Chin K, Hatsuno T, Kajikawa M, Miura K, Horisawa M.
    Gan To Kagaku Ryoho; 2005 May; 32(5):637-9. PubMed ID: 15918563
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer.
    Ramnath N, LoRusso P, Simon M, Martino S.
    Am J Clin Oncol; 1997 Aug; 20(4):368-72. PubMed ID: 9256891
    [Abstract] [Full Text] [Related]

  • 29. Toxicity of WR-2721 administered in single and multiple doses.
    Kligerman MM, Glover DJ, Turrisi AT, Norfleet AL, Yuhas JM, Coia LR, Simone C, Glick JH, Goodman RL.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1773-6. PubMed ID: 6090369
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM, Spellman JM, Culo F.
    Cancer Clin Trials; 1980 Sep; 3(3):211-6. PubMed ID: 6254681
    [Abstract] [Full Text] [Related]

  • 32. Phase I/II trials of WR-2721 and cis-platinum.
    Glover D, Glick JH, Weiler C, Fox K, Turrisi A, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1509-12. PubMed ID: 3019969
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phase I trials of WR-2721 and cis-platinum.
    Glover D, Glick JH, Weiler C, Yuhas J, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1781-4. PubMed ID: 6090371
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of the radioprotector WR 2721 on the response of metastatic Lewis lung carcinoma colonies to alkylating agents.
    Wist EA.
    Acta Radiol Oncol; 1985 Sep; 24(3):259-62. PubMed ID: 2994377
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase I controlled trials of WR-2721 and cyclophosphamide.
    Glick JH, Glover D, Weiler C, Norfleet L, Yuhas J, Kligerman MM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1777-80. PubMed ID: 6090370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.